The pro-inflammatory cytokines, IL-1β and TNF-α, inhibit intestinal alkaline phosphatase gene expression

DNA and Cell Biology

Volumn 25, Issue 12, 2006, Pages 684-695

  Malo, Madhu S ^a   Biswas, Shaluk ^a   Abedrapo, Mario A ^a   Yeh, Lisa ^a   Chen, Alexander ^a   Hodin, Richard A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BACTERIUM LIPOPOLYSACCHARIDE; BUTYRIC ACID; CYTOKINE; FAT; FATTY ACID; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; HISTONE H3; HISTONE H4; INTERLEUKIN 1BETA; INTESTINE ENZYME; TUMOR NECROSIS FACTOR ALPHA;

ACETYLATION; ALKALINE PHOSPHATASE GENE; ARTICLE; CELL FUNCTION; CELL STRAIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENTERITIS; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME INDUCTION; ENZYME INHIBITION; EPITHELIUM CELL; FUNCTIONAL PROTEOMICS; GENE; GENE ACTIVATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE SILENCING; HUMAN; HUMAN CELL; INTESTINE MUCOSA; LIPID ABSORPTION; NORTHERN BLOTTING; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPORTER GENE; TRANSIENT TRANSFECTION; WESTERN BLOTTING;

ACETYLATION; ACETYLTRANSFERASES; ANTIGENS, NEOPLASM; BUTYRATES; CELL SURVIVAL; GENE EXPRESSION REGULATION; GENE SILENCING; GENES, REPORTER; HCT116 CELLS; HISTONE ACETYLTRANSFERASES; HT29 CELLS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; LUCIFERASES; PROMOTER REGIONS (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS);

EID: 33845994373     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2006.25.684     Document Type: Article

References (81)

1. ACHARYA, M.R., SPARREBOOM, A., VENITZ, J., and FIGG, W.D. (2005). Rational development of histone deacetylase inhibitors as anticancer agents: A review. Mol. Pharmacol. 68, 917-932.
2. ARCHER, S.Y., MENG, S., SHEI, A., and HODIN, R.A. (1998). p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc. Natl. Acad. Sci. USA 95, 6791-6796.
3. ARCHER, S.Y., JOHNSON, J.J., KIM, H.J., and HODIN, R.A. (2001). p21 gene regulation during enterocyte differentiation. J. Surg. Res. 98, 4-8.
4. ASHBURNER, B.P., WESTERHEIDE, S.D., BALDWIN, A.S., JR. (2001). The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol. Cell Biol. 21, 7065-7077.
5. AUGERON, C., and LABOISSE, C.L. (1984). Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture alter treatment with sodium butyrate. Cancer Res. 44, 3961-3969.
6. BAI, L., KAO, J.Y., LAW, D.J., and MERCHANT, J.L. (2006). Recruitment of ataxia-telangiectasia mutated to the p21(waf1) promoter by ZBP-89 plays a role in mucosal protection. Gastroenterology 131, 841-852.
7. BAUD, V., and KARIN, M. (2001). Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11, 372-377.
8. BERG, S., SAPPINGTON, P.L. GUZIK, L.J., DELUDE, R.L., and FINK, M.P. (2003). Proinflammatory cytokines increase the rate of glycolysis and adenosine-5′-triphosphate turnover in cultured rat enterocytes. Crit. Care Med. 31, 1203-1212.
9. BEUMER, C., WULFERINK, M., RAABEN, W., FIECHTER, D., BRANDS, R., and SEINEN, W. (2003). Calf intestinal alkaline phosphatase, a novel therapeutic drug for lipopolysaccharide (LPS)-mediated diseases, attenuates LPS toxicity in mice and piglets. J. Pharmacol. Exp. Ther. 307, 737-744.
10. BREUER, R.I., BUTO, S.K., CHRIST, M.L., BEAN, J., VERNIA, P., PAOLUZI, P., DI PAOLO, M.C., and CAPRILLI, R. (1991). Rectal irrigation with short-chain fatty acids for distal ulcerative colitis. Preliminary report. Dig. Dis. Sci. 36, 185-187.
11. BODE, H., SCHMITZ, H., FROMM, M., SCHOLZ, P., RIECKEN, E.O., and SCHULZKE, J.D. (1998). IL-1beta and TNF-alpha, but not IFN-alpha, IFN-gamma, IL-6 or IL-8, are secretory mediators in human distal colon. Cytokine 10, 457-465.
12. BRASSE-LAGNEL, C., LAVOINNE, A., FAIRAND, A., VAVASSEUR, K., and HUSSON, A. (2005). IL-1beta stimulates argininosuccinate synthetase gene expression through NF-kappaB in Caco-2 cells. Biochimie 87, 403-409.
13. CAO, Z., TANAKA, M., REGNIER, C., ROTHE, M., YAMIT-HEZI, A., WORONICZ, J.D., FUENTES, M.E., DURNIN, M.H., DALRYMPLE, S.A., and GOEDDEL, D.V. (1999). NF-kappa B activation by tumor necrosis factor and imerleukin-1. Cold Spring Harb. Symp. Quant. Biol. 64, 473-483.
14. CHANG, H.G., MORSE, D.L., NOONAN, C., COLES, B., MIKL, J., ROSEN, A., PUTNAM, D., and SMITH, P.F. (1993). Survival and mortality patterns of an acquired immunodeficiency syndrome (AIDS) cohort in New York State. Am. J. Epidemiol. 138, 341-349.
15. CHAVEZ, A.M., MENCONI, M.J., HODIN, R.A., and FINK, M.P. (1999). Cytokine-induced intestinal epithelial hyperpermeability: Role of nitric oxide. Crit. Care Med. 27, 2246-2251.
16. CHOWERS, Y., MARSH, M.N., DE GRANDPRE, L., NYBERG, A., THEOFILOPOULOS, A.N., and KAGNOFF, M.F. (1997). Increased proinflammalory cytokine gene expression in the colonic mucosa of coeliac disease patients in the early period after gluten challenge. Clin. Exp. Immunol. 107, 141-147.
17. CLEVELAND, D.W., LOPATA, M.A., MACDONALD, R.J., COWAN, N.J., RUTTER, W.J., and KIRSCHNER, M.W. (1980). Number and evolutionary conservation of alpha- and beta-tubulin and cytoplasmic beta- and gamma-actin genes using specific cloned cDNA probes. Cell 20, 95-105.
18. COURTOIS, F., SUC, I., GAROFALO, C., LEDOUX, M., SEIDMAN, E., and LEVY, E. (2000). Iron-ascorbate alters the efficiency of Caco-2 cells to assemble and secrete lipoproteins. Am. J. Physiol. 279, G12-G19.
19. COUSENS, L.S., GALLWITZ, D., and ALBERTS, B.M. (1979). Different accessibilities in chromatin to histone acetylase. J. Biol. Chem. 254, 1716-1723.
20. DANIELS, I., CAVILL, D., MURRAY, I.A., and LONG, R.G. (2005). Elevated expression of iNOS mRNA and protein in coeliac disease. Clin. Chim. Acta. 356, 134-142 (Epub 2005 Apr 7).
21. DAVIE, J.R. (2003). Inhibition of histone deacetylase activity by butyrate. J. Nutr. 133, 2485S-2493S.
22. DING, W.X., and YIN, X.M. (2004). Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury. J. Cell Mol. Med. 8, 445-454.
23. DIONNE, S., D'AGATA, I.D., HISCOTT, J., VANOUNOU, T., and SEIDMAN, E.G. (1998). Colonic explant production of IL-1 and its receptor antagonist is unbalanced in inflammatory bowel disease (IBD). Clin. Exp. Immunol. 112, 435-442.
24. SABATINO, A., MORERA, R., CICCOCIOPPO, R., CAZZOLA, P., GOTTI, S., TINOZZI, F.P., TINOZZI, S., and CORAZZA, G.R. (2005). Oral butyrate for mildly to moderately active Crohn's disease. Aliment Pharmacol. Ther. 22, 789-794.
25. DUBE, N., DELVIN, E., YOTOV, W., GAROFALO, C., BENDAYAN, M., VEERKAMP, J.H., and LEVY, E. (2001). Modulation of intestinal and liver fatty acid-binding proteins in Caco-2 cells by lipids, hormones and cytokines. J. Cell Biochem. 81, 613-620.
26. FITZGERALD, R.C., ABDALLA, S., ONWUEGBUSI, B.A., SIRIEIZ, P., SAEED, I.T., BURNHAM, W.R., and FARTHING, M.J. (2002). Inflammatory gradient in Barrett's oesophagus: Implications for disease complications. Gut 51, 316-322.
27. GARCIA HERRERA, J., NAVARRO, M.A., MARCA, M.C., DE LA OSADA, J., and RODRIGUEZ-YOLDI, M.J. (2004). The effect of tumor necrosis factor-alpha on D-fructose intestinal transport in rabbits. Cytokine 25, 21-30.
28. GITTER, A.H., BENDFELDT, K., SCHMITZ, H., SCHULZKE, J.D., BENTZEL, C.J., and FROMM, M. (2000). Epithelial barrier defects in HT-29/B6 colonic cell monolayers induced by tumor necrosis factor-alpha. Ann. N. Y. Acad. Sci. 915, 193-203.
29. GUPTA, S., and GOLLAPUDI, S. (2006). Molecular mechanisms of TNF alpha-induced apoptosis in naive and memory T cell subsets. Autoimmun. Rev. 4, 264-268. (Epub 2005 Sep 30).
30. HAN, X., FINK, M.P., and DELUDE, R.L. (2003). Proinflammatory cytokines cause NO*-dependent and -independent changes in expression and localization of tight junction proteins in intestinal epithelial cells. Shock 19, 229-237.
31. HARIG, J.M., SOERGEL, K.H., KOMOROWSKI, R.A., WOOD, C.M. (1989). Treatment of diversion colitis with short-chain-fatty acid irrigation. N. Engl. J. Med. 320, 23-28.
32. HARPER, J.W., ADAMI, G.R., WEI, N., KEYOMARSI, K., and ELLEDGE, S.J. (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816.
33. HENTHORN, P.S., RADUCHA, M., KADESCH, T., WEISS, M.J., and HARRIS, H. (1988). Sequence and characterization of the human intestinal alkaline phosphatase gene. J. Biol. Chem. 263, 12011-12019.
34. HINNEBUSCH, B.F., MENG, S., WU, J.T., ARCHER, S.Y., and HODIN, R.A. (2002). The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J. Nutr. 132, 1012-1017.
35. HINNEBUSCH, B.F., HENDERSON, J.W., SIDDIQUE, A., MALO, M.S., ZHANG, W., ABEDRAPO, M.A., and HODIN, R.A. (2003). Transcriptional activation of the enterocyte differentiation marker intestinal alkaline phosphatase is associated with changes in the acetylation state of histone H3 at a specific site within its promoter region in vitro. J. Gastrointest. Surg. 7, 237-244; discussion 244-245.
36. HINNEBUSCH, B.F., SIDDIQUE, A., HENDERSON, J.W., MALO, M.S., ZHANG, W., ATHAIDE, C.P., ABEDRAPO, M.A., CHEN, X., YANG, V.W., and HODIN, R.A. (2004). Enterocyte differentiation marker intestinal alkaline phosphatase is a target gene of the gut-enriched Kruppel-like factor. Am. J. Physiol. 286, G23-G30. (Epub 2003 Aug 14).
37. HODIN, R.A., MENG, S., ARCHER, S., and TANG, R. (1996). Cellular growth state differentially regulates enterocyte gene expression in butyrate-treated HT-29 cells. Cell Growth Differ. 7, 647-653.
38. HU, X. (2003). Proteolytic signaling by TNFalpha: Caspase activation and IkappaB degradation. Cytokine 21, 286-294.
39. JENUWEIN, T., and ALLIS, C.D. (2001). Translating the histone code. Science 293, 1074-1080.
40. KANDIL, O., FISHMAN, J.A., KOZIEL, H., PINKSTON, P., ROSE, R.M., and REMOLD, H.G. (1994). Human immunodeficiency virus type 1 infection of human macrophages modulates the cytokine response to Pneumocystis carinii. Infect. Immun. 62, 644-650.
41. KIM, J.H., MENG, S., SHEI, A., and HODIN, R.A. (1999). A novel Sp1-related cis element involved in intestinal alkaline phosphatase gene transcription. Am. J. Physiol. 276, G800-G807.
42. KLES, K.A., and CHANG, E.B. (2006). Short-chain fatty acids impact on intestinal adaptation, inflammation, carcinoma, and failure. Gastroenterology 130, S100-S105.
43. KONTAKOU, M., PRZEMIOSLO, R.T., STURGESS, R.P., LIMB, A.G., and CICLITIRA, P.J. (1995). Expression of tumour necrosis factor-alpha, interleukin-6, and interleukin-2 mRNA in the jejunum of patients with coeliac disease. Scand. J. Gastroenterol. 30, 456-463.
44. KOVARIKOVA, M., PACHERNIK, J., HOFMANOVA, J., ZADAK, Z., and KOZUBIK, A. (2000). TNF-alpha modulates the differentiation induced by butyrate in the HT-29 human colon adenocarcinoma cell line. Eur. J. Cancer. 36, 1844-1852.
45. LAFTAH, A.H., SHARMA, N., BROOKES, M.J., MCKIE, A.T., SIMPSON, R.J., IQBAL, T.H., and TSELEPIS, C. (2006). Tumour necrosis factor alpha causes hypoferraemia and reduced intestinal iron absorption in mice. Biochem. J. 397, 61-67.
46. MAHMOOD, A., SHAO, J.S., and ALPERS, D.H. (2003). Rat enterocytes secrete SLPs containing alkaline phosphatase and eubilin in response to corn oil feeding. Am. J. Physiol. 285, G433-G441.
47. MALO, M.S., ZHANG, W., ALKHOURY, F., PUSHPAKARAN, P., ABEDRAPO, M.A., MOZUMDER, M., FLEMING, E., SIDDIQUE, A., HENDERSON, J.W., and HODIN, R.A. (2004). Thyroid hormone positively regulates the enterocyte differentiation marker intestinal alkaline phosphatase gene via an atypical response element. Mol. Endocrinol. 18, 1941-1962.
48. MALO, M.S., MOZUMDER, M., ZHANG, X.B., BISWAS, S., CHEN, A., BAI, L.C., MERCHANT, J.L., and HODIN, R.A. (2006). Intestinal alkaline phosphatase gene expression is activated by ZBP-89. Am. J. Physiol. 290, G737-G746.
49. MCGOWAN, I., RADFORD-SMITH, G., and JEWELL, D.P. (1994). Cytokine gene expression in HIV-infected intestinal mucosa. AIDS 8, 1569-1575.
50. MEHRAN, M., SEIDMAN, E., MARCHAND, R., GURBINDO, C., and LEVY, E. (1995). Tumor necrosis factor-alpha inhibits lipid and lipoprotein transport by Caco-2 cells. Am. J. Physiol. 269, G953-G960.
51. MILLAN, J.L. (2006). The TSAP genes. In Mammalian Alkaline Phosphatases: From Biology to Applications in Medicine and Biotechnology. J.L. Millan, ed. (Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim).
52. NARISAWA, S., HUANG, L., IWASAKI, A., HASEGAWA, H., ALPERS, D.H., and MILLAN, J.L. (2003). Accelerated fat absorption in intestinal alkaline phosphatase knockout mice. Mol. Cell Biol. 23, 7525-7530.
53. PLACE, R.F., NOONAN, E.J., and GIARDINA, C. (2005). HDAC inhibition prevents NF-kappa B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I kappa B alpha. Biochem Pharmacol. 70, 394-406.
54. QIOVY, V., and VAN LINT, C. (2004). Regulation at multiple levels of NF-kappaB-mediated transactivation by protein acetylation. Biochem. Pharmacol. 68, 1221-1229.
55. RADEMA, S.A., TYTGAT, G.N., and VAN DEVENTER, S.J. (1995). In situ detection of interleukin-1 beta and interleukin 8 in biopsy specimens from patients with ulcerativc colitis. Adv. Exp. Med. Biol. 371B, 1297-1299.
56. RAHMAN, I., MARWICK, J., and KIRKHAM, P. (2004). Redox modulation of chromatin remodeling: Impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression. Biochem. Pharmacol. 68, 1255-1267.
57. REIMUND, J.M., WITTERSHEIM, C., DUMONT, S., MULLER, C.D., BAUMANN, R., POINDRON, P., and DUCLOS, B. (1996). Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease. J. Clin. Immunol. 16, 144-150.
58. REINECKER, H.C., STEFFEN, M., WITTHOEFT, T., PFLUEGER, I., SCHREIBER, S., MACDERMOTT, R.P., and RAEDLER, A. (1993). Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin. Exp. Immunol. 94, 174-181.
59. SANDBORN, W.J., STENSON, W.F., BRYNSKOV, J., LORENZ, R.G., STEIDLE, G.M., ROBBINS, J.L., KENT, J.D., and BLOOM, B.J. (2006). Safety of celecoxib in patients with ulcerative colitis in remission: A randomized, placebo-controlled, pilot study. Clin. Gastroenterol. Hepatol. 4, 203-211.
60. SANTOS-ROSA, H., and CALDAS, C. (2005). Chromatin modifier enzymes, the histone code and cancer. Eur. J. Cancer 41, 2381-2402.
61. SAPPINGTON, P.L., HAN, X., YANG, R., DELUDE, R.L., and FINK, M.P. (2003). Ethyl pyruvate ameliorates intestinal epithelial barrier dysfunction in endotoxemic mice and immunostimulated caco-2 enterocytic monolayers. J. Pharmacol. Exp. Ther. 304, 464-476.
62. SCHARTE, M., HAN, X., BERTGES, D.J., FINK, M.P., and DELUDE, R.L. (2003). Cytokines induce HIF-1 DNA binding and the expression of HIF-1-dependent genes in cultured rat enterocytes. Am. J. Physiol. 284, G373-G384.
63. SCHEPPACH, W., SOMMER, H., KIRCHNER, T., PAGANELLI, G.M., BARTRAM, P., CHRISTL, S., RICHTER, F., DUSEL, G., and KASPER, H. (1992). Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 103, 51-56.
64. + secretion in human distal colon driven by prostaglandin E2. Am. J. Physiol. 271, G669-G674.
65. SCHUTZE, S., WIEGMANN, K., MACHLEIDT, T., and KRONKE, M. (1995). TNF-induced activation of NF-kappa B. Immunobiology. 193, 193-203.
66. SHIE, J.L., CHEN, Z.Y., O'BRIEN, M.J., PESTELL, R.G., LEE, M.E., and TSENG, C.C. (2000). Role of gut-enriched Kruppel-like factor in colonic cell growth and differentiation. Am. J. Physiol. 279, G806-G814.
67. SIZEMORE, N., LEUNG, S., and STARK, G.R. (1999). Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit. Mol. Cell Biol. 19, 4798-4805.
68. STEINHART, A.H., BRZEZINSKI, A., and BAKER, J.P. (1994). Treatment of refractory ulcerative proctosigmoiditis with butyrate enemas. Am. J. Gastroenterol. 89, 179-183.
69. STEINHART, A.H., HIRUKI, T., BRZEZINSKI, A., and BAKER, J.P. (1996). Treatment of left-sided ulcerative colitis with butyrate enemas: A controlled trial. Aliment Pharmacol. Ther. 10, 729-736.
70. THIAGALINGAM, S., CHENG, K.H., LEE, H.J., MINEVA, N., THIGALINGAM, A., and PONTE, J.F. (2003). Histone deacetylases: Unique players in shaping the epigenetic histone code. Ann. N. Y. Acad. Sci. 983, 84-100.
71. TONELLI, F., DOLARA, P., BATIGNANI, G., MONACI, I., CADERNI, G., SPAGNESI, M.T., LUCERI, C., and AMOROSI, A. (1995). Effects of short chain fatty acids on mucosal proliferation and inflammation of ileal pouches in patients with ulcerative colitis and familial polyposis. Dis. Colon Rectum. 38, 974-978.
72. VERNIA, P., FRACASSO, P.L., CASALE, V., VILLOTTI, G., MARCHEGGIANO, A., STIGLIANO, V., PINNARO, P., BAGNARDI, V., and CAPRILLI, R. (2000). Topical butyrate for acute radiation proctitis: Randomised, crossover trial. Lancet. 356, 1232-1235.
73. VERNIA, P., ANNESE, V., BRESCI, G., D'ALBASIO, G., D'INCA, R., GIACCARI, S., INGROSSO, M., MANSI, C., RIEGLER, G., VALPIANI, D., et al. (2003). Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: Results of a multicentre trial. Eur. J. Clin. Invest. 33, 244-248.
74. VICTOR, F.C., and GOTTLIEB, A.B. (2002). TNF-alpha and apoptosis: Implications for the pathogenesis and treatment of psoriasis. J. Drugs Dermatol. 1, 264-275.
75. WANG, D., and BALDWIN, A.S., JR. (1998). Activation of nuclear factor-kappaB-dependent transcription by tumor necrosis factor alpha is mediated through phosphorylation of RelA/p65 on serine 529. J. Biol. Chem. 273, 29411-29416.
76. WANG, L.H., FANG, X.C., and PAN, G.Z. (2004). Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut 53, 1096-1101.
77. WILCOX, C.M., HARRIS, P.R., REDMAN, T.K., KAWABATA, S., HIROI, I., KIYONO, H., and SMITH, P.D. (1998). High mucosal levels of tumor necrosis factor alpha messenger RNA in AIDS-associated cytomegalovirus-induced esophagitis. Gastroenterology 114, 77-82.
78. WOYWODT, A., NEUSTOCK, P., KRUSE, A., SCHWARTING, K., LUDWIG, D., STANGE, E.F., and KIRCHNER, H. (1994). Cytokine expression in intestinal mucosal biopsies. In situ hybridisation of the mRNA for interleukin-1 beta, interleukin-6 and tumour necrosis factor-alpha in inflammatory bowel disease. Eur. Cytokine Netw. 5, 387-395.
79. ZHANG, W., and KONE, B.C. (2002). NF-kappaB inhibits transcription of the H(+)-K(+)-ATPase alpha(2)-subunit gene: Role of histone deacetylases. Am. J. Physiol. 283, F904-F911.
80. ZHONG, H., MAY, M.J., JIMI, E., GHOSH, S. (2002). The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol. Cell. 9, 625-636.
81. ZIAMBARAS, T., RUBIN, D.C., and PERLMUTTER, D.H. (1996). Regulation of sucrase-isomaltase gene expression in human intestinal epithelial cells by inflammatory cytokines. J. Biol. Chem. 271, 1237-1242.